CTRI/2021/02/031462
Not Yet Recruiting
N/A
Biomarkers for Inborn Errors of Metabolism AN INTERNATIONAL, MULTICENTER, OBSERVATIONAL, LONGITUDINAL STUDY
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: E70-E88- Metabolic disorders
- Sponsor
- Centogene AG
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Informed consent is obtained from the participant or from their parent/legal guardian, before any study related procedures
- •2\. The participant aged between 2 months old and 40 years old
- •3\. The diagnosis of an Inborn Error of Metabolism is genetically confirmed
Exclusion Criteria
- •1\. Inability to provide informed consent
- •2\. The participant is younger than 2 months old or older than 40 years old
- •3\. The diagnosis of an Inborn Error of Metabolism (IEM) is not genetically confirmed
- •4\. Previously enrolled in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Biomarkers for Inborn Errors of MetabolismInborn Errors of MetabolismBiomarkerNCT04098198CENTOGENE GmbH Rostock462
Recruiting
N/A
Search of biomarkers for metabolic abnormalities of cholesterol by comprehensive analysis of cholesterol metabolites in human body fluidInborn error of metabolism (Niemann-Pick disease type C, 3beta-hydroxy-delta5-C27-steroid dehydrogenase/isomerase (3beta-HSD) defficiency, lysosomal storage disorder, etc), hepatobiliary diaseses (steatosis, NAFLD, NASH, ALD, hepatitis B, hepatitis C, primary biliary cirrhosis, cholangitis, hepatic carcinoma)JPRN-UMIN000017343Department of Pharmaceutical Sciences, Tohoku university hospital60
Recruiting
N/A
Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in KazakhstanPropionic/Methylmalonic AcidemiasMaple Syrup Urine DiseaseCitrullinemiaArgininosuccinic AciduriaOrnithine Transcarbamylase DeficiencyCarbamoyl Phosphate Synthetase I DeficiencyN-acetylglutamate Synthase DeficiencyNonketotic HyperglycinemiaTyrosinemiaHomocystinuriaArginase DeficiencyIsovaleric AcidemiaShort/Branched Chain Acyl-CoA Dehydrogenase DeficiencyIsobutyryl-CoA Dehydrogenase DeficiencyGlutaric Acidemia Type I3-methylcrotonyl-CoA Carboxylase DeficiencyBiotinidase DeficiencyMalonyl-CoA Decarboxylase DeficiencyBeta-ketothiolase Deficiency3-hydroxy-3-methylglutaryl-CoA Lyase Deficiency3-methylglutaconyl-CoA Hydratase DeficiencyMedium-chain Acyl-CoA Dehydrogenase DeficiencyVery Long-chain Acyl-CoA Dehydrogenase DeficiencyLong-chain 3-hydroxyacyl-CoA Dehydrogenase DeficiencyGlutaric Acidemia Type IIPrimary Carnitine DeficiencyCarnitine Palmitoyltransferase I DeficiencyCarnitine Palmitoyltransferase II DeficiencyCarnitine-acylcarnitine Translocase DeficiencyNCT05910151West Kazakhstan Medical University2,250
Enrolling by Invitation
N/A
Genetic Diagnosis in Inborn Errors of MetabolismMetabolic DiseaseMitochondrial DiseasesEpilepsy in ChildrenEpilepsyLHONMotor Neuron DiseaseNCT06376279Region Stockholm1,000
Completed
N/A
Role of Metabolic Tests in Infants presenting with Developmental DelayHealth Condition 1: E889- Metabolic disorder, unspecifiedHealth Condition 2: F88- Other disorders of psychological developmentCTRI/2021/04/032521Dr Rochelle Natasha Gomes53